KBIS Limited

Date authorised
1 April 2013
Companies House
02208091
Last scraped
3 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    Cullimore House
    Peasemore
    Newbury
    West Berkshire
    RG20 7JN
    UNITED KINGDOM
    Phone
    +4402079774800
    Web
    https://www.kbis.co.uk

  • Complaints Contact

    7th Floor
    The St Botolph Building
    138 Houndsditch
    London
    EC3A 7AW
    UNITED KINGDOM
    Phone
    +4402079774800

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Investment Advice (no pensions)

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.

  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Insurance Admin

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Credit Brokering

  • Stockbroking

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Charles Love

    IRN CXL07672

    • SMF3 Executive Director (25 May 2021 to 3 Mar 2022)
  • Charlotte Rose Mockford

    IRN CXM11707

    • [FCA CF] Significant management (19 Oct 2022 to 20 Feb 2026)
    • SMF3 Executive Director (9 Dec 2019 to 22 Jul 2022)
    • CF1 Director (15 Apr 2019 to 8 Dec 2019)
  • Christopher Allen Gagg

    IRN CAG01164

    • [FCA CF] CASS oversight function (since 19 Oct 2022)
  • Christopher James Hodgson

    IRN CJH01120

    • CF29 Significant management (1 Nov 2007 to 12 Jul 2011)
    • CF17 Significant Mgt (Other Business Operations) (25 Jan 2005 to 31 Oct 2007)
    • CF2 Non Executive Director (25 Jan 2005 to 8 Dec 2019)
  • Clare Louise Lebecq

    IRN CXL00278

    • SMF3 Executive Director (21 Jul 2022 to 24 Sep 2024)
  • Daniel Thomas Parry

    IRN DTP01030

    • CF29 Significant management (6 Feb 2008 to 12 Jul 2011)
    • CF28 Systems and controls (6 Feb 2008 to 12 Jul 2011)
    • CF10 Compliance Oversight (6 Feb 2008 to 12 Jul 2011)
    • Responsible for Insurance Mediation (6 Feb 2008 to 17 Jan 2014)
    • CF1 Director (6 Feb 2008 to 8 Dec 2017)
  • Elizabeth Anne Prest

    IRN EAP01028

    • SMF3 Executive Director (since 9 Dec 2019)
    • CF29 Significant management (1 Nov 2007 to 12 Jul 2011)
    • CF28 Systems and controls (1 Nov 2007 to 12 Jul 2011)
    • CF14 Risk Assessment (14 Jan 2005 to 31 Oct 2007)
    • CF17 Significant Mgt (Other Business Operations) (14 Jan 2005 to 31 Oct 2007)
    • CF8 Apportionment and Oversight (14 Jan 2005 to 31 Mar 2009)
    • Responsible for Insurance Mediation (14 Jan 2005 to 17 Jan 2014)
    • CF1 Director (14 Jan 2005 to 8 Dec 2019)
    • CF13 Finance (14 Jan 2005 to 31 Oct 2007)
  • Emma Cover

    IRN EXC12966

    • [FCA CF] Significant management (20 Oct 2022 to 20 Feb 2026)
    • SMF3 Executive Director (9 Dec 2019 to 22 Jul 2022)
    • CF1 Director (5 Jun 2019 to 8 Dec 2019)
  • Guy Robert Prest

    IRN GRP01056

    • SMF3 Executive Director (since 9 Dec 2019)
    • SMF1 Chief Executive (9 Dec 2019 to 21 Jan 2025)
    • Responsible for Insurance Distribution (1 Oct 2018 to 21 Jan 2025)
    • CF29 Significant management (1 Nov 2007 to 12 Jul 2011)
    • CF28 Systems and controls (1 Nov 2007 to 12 Jul 2011)
    • CF8 Apportionment and Oversight (14 Jan 2005 to 31 Mar 2009)
    • Responsible for Insurance Mediation (14 Jan 2005 to 30 Sep 2018)
    • CF14 Risk Assessment (14 Jan 2005 to 31 Oct 2007)
    • CF1 Director (14 Jan 2005 to 8 Dec 2019)
    • CF13 Finance (14 Jan 2005 to 31 Oct 2007)
    • CF15 Internal Audit (14 Jan 2005 to 31 Oct 2007)
    • CF17 Significant Mgt (Other Business Operations) (14 Jan 2005 to 31 Oct 2007)
    • CF3 Chief Executive (14 Jan 2005 to 8 Dec 2019)
  • Harriet Walker

    IRN HXW00004

    • [FCA CF] Significant management (20 Oct 2022 to 20 Feb 2026)
    • SMF3 Executive Director (10 Nov 2020 to 22 Jul 2022)
Show more

Appointed representatives

Smaller firms operating under this firm's FCA authorisation.

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.